We’ve reported on the RECOVERY trial several times already on the blog. It stands out as the most important trial of therapeutics in hospitalised patients with COVID19. In the last […]
High dose vs. Low dose steroids in hospitalised COVID 19 patients. St Emlyn’s. Read More
We’ve reported on the RECOVERY trial several times already on the blog. It stands out as the most important trial of therapeutics in hospitalised patients with COVID19. In the last
Baricitinib for hospitalised COVID19 patients. St Emlyn’s Read More
‘The anticipation of touch is one of the most potent sensations on Earth‘ Richard J. Finch Usually, around Christmas time I can set a record for the amount of hugs
To Touch or not to Touch that is the Question. Touch and COVID19 Read More
I remember back at the beginning of the pandemic when we were seeing lots of patients arriving in the ED in extremis. The now familiar picture of the deeply hypoxic
JC: Non-invasive ventilation for COVID 19 patients. The Recovery RS trial. St Emlyn’s Read More
Back in March we reported on a pre-print trial of thromboprophylaxis of ICU patients. The results suggested that there was no benefit for therapeutic dose anticoagulation in COVID19 as a prophylactic strategy for
JC: Thromboprophylaxis for the non ICU hospitalised COVID-19 patient. St Emlyn’s Read More
We’ve reported on the RECOVERY trial several times already on the blog. It stands out as the most important trial of therapeutics in hospitalised patients with COVID19. In the last
REGN monoclonal antibodies work in selected hospitalised COVID-19 patients. St Emlyn’s Read More
We’ve reported on the RECOVERY trial several times already on the blog. It stands out as the most important trial of therapeutics in hospitalised patients with COVID19. This week the
JC: Aspirin is not effective for hospitalised COVID19 patients. St Emlyn’s Read More
The prevention of venous thromboembolism (VTE) has been a real concern in the management of hospitalised patients with COVID-19. We have previously discussed the role of prophylactic anticoagulation (thromboprophylaxis) for
JC: Thromboprophylaxis on the ICU for COVID-19 patients. St Emlyn’s Read More
The latest results on the use of convalescent plasma in Covid-19 are now out from the RECOVERY trial as a pre-print. As you know we have already covered the trial
JC: Convalescent plasma (still) does not work in COVID-19. St Emlyn’s Read More
This week the RECOVERY trial has released the first results from the Colchicine arm of the trial. We await the pre-print and the peer reviewed paper, but we are already
Colchicine does not improve mortality in COVID19. St Emlyn’s Read More
